US 11207299
Biphenyl sulfonamide compounds for the treatment of type IV collagen diseases
granted A61KA61K31/422A61K45/06
Quick answer
US patent 11207299 (Biphenyl sulfonamide compounds for the treatment of type IV collagen diseases) held by Travere Therapeutics, Inc. expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Travere Therapeutics, Inc.
- Grant date
- Tue Dec 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/422, A61K45/06, A61K9/00, A61K9/0053